SalubrisBio, founded in August 2016 as a subsidiary of China-based Salubris Pharmaceuticals Co. Ltd., is headquartered in Gaithersburg, Maryland. The company is dedicated to pioneering research and development in the biotech sector, focusing on creating innovative and transformative therapeutic molecules. SalubrisBio specializes in developing novel antibody and protein-based therapeutics aimed at providing significant clinical improvements for patients with unmet medical needs.
Notable affiliated individuals include key researchers and executives from both SalubrisBio and its parent company, Salubris Pharmaceuticals. The company has achieved several milestones in advancing its clinical-stage biotechnology programs. Its innovative approach has made a substantial impact on the biotech industry, particularly in addressing complex diseases with high unmet medical needs.
